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Abstract
Malaria threatens half the world’s population and exacts a devastating human toll. The principal malaria vector in Africa, the
mosquito Anopheles gambiae, encodes 24 members of a recently identified family of leucine-rich repeat proteins named
LRIMs. Two members of this family, LRIM1 and APL1C, are crucial components of the mosquito complement-like pathway
that is important for immune defense against Plasmodium parasites. LRIM1 and APL1C circulate in the hemolymph
exclusively as a disulfide-bonded complex that specifically interacts with the mature form of the complement C3-like
protein, TEP1. We have investigated the specificity of LRIM1/APL1C complex formation and which regions of these proteins
are required for interactions with TEP1. To address these questions, we have generated a set of LRIM1 and APL1C alleles
altering key conserved structural elements and assayed them in cell culture for complex formation and interaction with
TEP1. Our data indicate that heterocomplex formation is an intrinsic ability of LRIM1 and APL1C and identify key
homologous cysteine residues forming the intermolecular disulfide bond. We also demonstrate that the coiled-coil domain
is the binding site for TEP1 but also contributes to the specificity of LRIM1/APL1C complex formation. In addition, we show
that the LRIM1/APL1C complex interacts with the mature forms of three other TEP proteins, one of which, TEP3, we have
characterized as a Plasmodium antagonist. We conclude that LRIM1 and APL1C contain three distinct modules: a C-terminal
coiled-coil domain that can carry different TEP protein cargoes, potentially with distinct functions, a central cysteine-rich
region that controls complex formation and an N-terminal leucine-rich repeat with a putative role in pathogen recognition.
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Introduction
The innate immune system is the primary, and in some
organisms, such as insects, the sole means of defense against
infection. The main mosquito defense against invading Plasmodium
is orchestrated by a collection of hemolymph proteins that closely
resembles the vertebrate complement cascade [1]. The majority of
Plasmodium ookinetes traversing the mosquito midgut epithelium
and coming into contact with the hemolymph are attacked and
cleared by lysis or by encasement in a melanin capsule
(melanization). Both of these reactions are triggered by binding
on the parasite surface of the thioester-containing protein TEP1, a
homolog of the complement factor C3 [2]. The few parasites that
escape this reaction develop into oocysts and, protected by the
oocyst wall, amplify their numbers and differentiate into
sporozoites, the vertebrate infective form of Plasmodium.
How parasites are recognized by the mosquito immune system
and how complement activation is biochemically regulated remain
unanswered, but recent work has revealed that these reactions
involve complex networks of basally expressed proteins, including
LRIM1 and APL1C, two putative pathogen recognition receptors
of the leucine-rich repeat (LRR) immune protein (LRIM) family
[2,3,4,5,6,7,8,9,10]. LRIM1 and APL1C circulate in the mosquito
hemolymph as a disulfide-bonded high-molecular weight complex
and are major antagonists of mosquito infections with the rodent
parasite P. berghei [6]. Silencing the genes that encode LRIM1,
APL1C and TEP1 transforms a refractory A. gambiae strain into a
susceptible strain [2,6]. Importantly, this triumvirate of proteins
contribute to resistance against Plasmodium of the non-vector
mosquito A. quadriannulatus A; their silencing renders these
mosquitoes permissive vectors [11]. The LRIM1/APL1C complex
interacts with proteolytically processed (mature) TEP1 in the
mosquito hemolymph [5,6]. This interaction stabilizes this mature
and reactive form of TEP1, promoting its binding to the parasite
surface and preventing its reaction with self.
LRIM1 and APL1C share several conserved structural features
including a signal peptide, an LRR domain, a pattern of cysteine
residues and a C-terminal coiled-coil domain [6,12]. LRR
domains are common in immune receptors and are flexible in
their binding properties, e.g. Toll-like receptors [13] and the
variable lymphocyte receptors of jawless vertebrates [14], while
coiled-coil domains often mediate protein-protein interactions.
The three-dimensional structure of the LRIM1/APL1C heterodi-
mer has been recently determined, revealing the presence of a
single disulfide bond between the two proteins formed by
conserved cysteine residues and providing a structural framework
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for elucidation of the function of this innate immune complex [15].
We designed a structure-function biochemical study to further our
understanding of the interactions between LRIM1 and APL1C,
and to investigate the role of their constituent domains in
interactions with TEP1 and other immune proteins. Using a
panel of engineered LRIM1 and APL1C alleles we reveal that the
cysteine-rich region between the LRR and coiled-coil domains is
crucial for LRIM1/APL1C complex formation and corroborate
the identity of the cysteines involved in the formation of the
disulfide bridge that is however not required for the interaction
between the LRIM1/APL1C complex and TEP1. We also show
that the coiled-coil domain is largely dispensable for complex
formation, but is essential for interactions with TEP1 as well as
with three other TEP family members, one of which we show to be
a potent antagonist of P. berghei infection. Our work reveals a
modular nature of the LRIM1/APL1C complex, which is
common in LRR-containing innate receptors, and demonstrates
that by carrying different cargoes this putative receptor may serve
distinct immune functions.
Results
LRIM1 and APL1C have an intrinsic ability to form
homo- and heterodimers
The LRIM1 and APL1C proteins circulate in the mosquito
hemolymph as a disulfide-linked complex. To determine whether
LRIM1 and APL1C have the intrinsic ability to form complexes or
if they require a cofactor, we expressed LRIM1 and APL1C alone
or together in Sf9 cells, an insect cell line derived from the
lepidopteran, Spodoptera frugiperda. Given that the LRIM family is
mosquito specific, a non-mosquito derived cell line should lack
potential interacting partners. For these experiments and those
described below we used expression constructs containing LRIM1
and APL1C transgenes that incorporate Strep and His epitope tags
on the N- and C-termini, respectively [6]. Following transfection,
conditioned medium (CM) was collected from the cells and
analyzed by western blot of non-reducing (NR) sodium dodecyl
sulfate polyacrylamide gels (SDS-PAGE) using antibodies against
LRIM1 and APL1C. CM collected from cells transfected with
LRIM1 or APL1C show that each protein individually has the
ability to form a high-molecular weight homomeric complex
(Figure 1). Co-transfection of LRIM1 and APL1C together
preferentially yields a complex intermediate in size compared to
their single transfections. As expected due to the presence of the
tags, the LRIM1/APL1C heterocomplex is slightly larger than the
untagged native complex present in the mosquito hemolymph.
Given the observed sizes of the monomeric tagged LRIM1 and
APL1C (63 and 97 kDa, respectively) the size of the complexes
produced by single (169 and 235 kDa) and double transfections
(197 kDa) best fit with homotrimers and heterotrimers. However,
the stoichiometry of the LRIM1/APL1C complex was recently
determined to be a heterodimer using techniques that are not
influenced by protein shape [15]. The same study also showed that
both LRIM1 and APL1C could form homodimers. Therefore, the
LRIM1/APL1C complex appears to migrate aberrantly slowly on
SDS-PAGE gels as is commonly reported for proteins containing
coiled-coils [16,17,18].
Given that the LRIM1/APL1C complex is held together by
disulfide bonds, cysteine residues are implicated as a key feature in
complex formation [6]. In addition, the coiled-coil domains of
LRIM1 and APL1C are in direct apposition to each other in the
crystal structure [15] suggesting these domains may instruct the
correct assembly of LRIM1/APL1C complexes. To assay the
contribution of the conserved cysteine residues and coiled-coil
domain in complex formation, we engineered alleles of these
features based on the LRIM1 and APL1C expression constructs
described above (Figure 2). Cysteine to serine missense mutations
were generated for each of the 5 conserved cysteine residues of
LRIM1 located between the LRR and coiled-coil domains
(C273S, C305S, C317S, C318S, C352S). A single cysteine
missense mutation of APL1C was generated (C562S) that targets
the cysteine residue homologous to LRIM1 C352. The residue
number of this cysteine in APL1C matches the A. gambiae PEST
genome reference strain but differs from what was reported by
Baxter and coworkers [15] which is likely due to a difference in the
polymorphic region of PANGGL repeats [8,12]. In addition, our
previous unpublished observations indicated that LRIM4, another
member of the Long subfamily of LRIM proteins, forms a
disulfide-bonded homodimer. LRIM4 lacks a cysteine residue
homologous to LRIM1 C352 or APL1C C562 [12]. Instead
LRIM4 contains a cysteine residue (C535) at its extreme C-
terminus, following the coiled-coil domain (Figure 2). We
generated a missense mutation of this residue in LRIM4
(C535S) to determine whether it is responsible for homodimer
formation. As LRIM1 and APL1C have bipartite coiled-coil
domains with greater than 80% confidence to have the ability to
form multimers (Figure S1) [19], we generated two alleles that
remove each region separately (DCCa and DCCb) and two alleles
that remove the coiled-coil domain altogether, one retaining
LRIM1 C352 and APL1C C562 (DCC1) and one deleting these
residues (DCC2) (Figure 2). Additionally, we created alternative
expression constructs for LRIM1, LRIM1C352S, APL1CC562S and
APL1CDCC1 containing a C-terminal Herpes Simplex Virus
(HSV) epitope tag, as some assays required proteins lacking a
His tag.
Analysis of conserved cysteine residues in LRIM1/APL1C
complex formation
To determine which conserved cysteine residues of LRIM1
contribute to homo- and heterodimer formation, we collected
samples of CM from transfected Sf9 cells and analyzed them by
NR western blot. Of the 5 alleles, only LRIM1C352S produced a
protein that was secreted into the CM (Figure 3A). Unlike wild-
type LRIM1, which is secreted as both a monomer and
Author Summary
The malaria-transmitting mosquito, Anopheles gambiae,
uses a complement-like pathway to defend against
Plasmodium parasites. The complement C3-like protein,
TEP1, binds to the surface of invading parasites, triggering
their destruction and clearance. LRIM1 and APL1C, two
leucine-rich repeat proteins, form a disulfide-bonded
complex which stabilizes mature TEP1 and promotes its
binding to parasites. Here, we investigate the structural
and biochemical features of the LRIM1/APL1C complex
and its interaction with TEP1. We identify key amino acid
residues responsible for covalently linking LRIM1 and
APL1C and the region of the complex where TEP1 binds.
Importantly, we demonstrate that the LRIM1/APL1C
complex can interact with the mature form of three other
TEPs, including TEP3, which we characterize as a novel
Plasmodium antagonist. Our results suggest that the
LRIM1/APL1C complex has a modular architecture in
which distinct functions map to different regions. Our
study provides important insights into how the A. gambiae
complement pathway helps mosquitoes fight against the
malaria parasite.
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homomeric complex, only monomeric LRIM1C352S was present in
the CM. We performed immunolocalization experiments using
both LRIM1 and Strep-tag antibodies and found that all cysteine
mutant proteins are produced (Figure S2). Therefore, disruption of
C273, C305, C317 and C318 prevents LRIM1 secretion. We next
co-expressed the LRIM1 cysteine alleles with wild-type APL1C to
determine if the presence of the wild-type partner would facilitate
secretion or complex formation. Even when co-expressed with
wild-type APL1C, LRIM1C273S, LRIM1C305S, LRIM1C317S and
LRIM1C318S were still absent from the CM. Similar to when it was
Figure 1. LRIM1 and APL1C form a heteromeric complex. Non-reducing western blot of mosquito hemolymph containing endogenous LRIM1
and APL1C and CM collected from Sf9 cells transfected with tagged LRIM1, APL1C or a secreted GFP (sGFP). The blot was probed simultaneously with
antibodies against LRIM1, APL1C and GFP. Indicated are Arrows: GFP, LRIM1 and APL1C monomers. Arrowheads: LRIM1 and APL1C homodimers,
white; LRIM1/APL1C heterodimers, black.
doi:10.1371/journal.ppat.1002023.g001
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expressed on its own, LRIM1C352S was present in the CM
exclusively as a monomer. Given the importance of C352 in the
ability of LRIM1 to form complexes, we tested whether a missense
allele of the homologous cysteine residue (C562) of APL1C (see
Figure 2) would behave similarly. We expressed APL1CC562S alone
or together with wild-type LRIM1 and found that in both cases the
protein was present in the CM only as a monomer (Figure 3B).
These data reveal a crucial role for the terminal conserved cysteine
Figure 2. Schematic representation of LRIM1, APL1C and LRIM4 cysteine and coiled-coil alleles generated. Predicted size of the mature
proteins indicated in gray. Features indicated: red line, cysteine residue; yellow star, cysteine to serine missense mutation; dashed line, in-frame
deletion. Colored boxes denote: black, signal peptide; blue, LRR repeats; green, coiled-coil domains. Names of cysteine alleles indicate amino acid
position of missense mutation relative to wild-type proteins. All amino acid positions are based on translation of the VectorBase mRNA sequences.
doi:10.1371/journal.ppat.1002023.g002
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Figure 3. LRIM1C352S, APL1CC562S and LRIM4C535S do not form disulfide-bonded complexes. Non-reducing (NR) and reducing (R) western
blot analysis of Sf9 cell CM samples following single transfection of indicated cysteine alleles (2) or co-transfection cysteine alleles together with wild-
type LRIM1 or APL1C (+). (A) Analysis of LRIM1 cysteine alleles using an antibody against LRIM1. (B) Analysis of APL1CC562S using an APL1C antibody.
(C) Analysis of wild-type LRIM4 and LRIM4C535S using His-probe. LRIM4 monomer and homodimer are indicated by an arrow or white arrowhead,
respectively. (D) Pull-down assays using different combinations of His- and HSV-tagged LRIM1C352S (LC352S) and APL1CC562S (AC562S) as indicated. The
presence of the proteins was verified in the starting CM (top panels). Following His-tag capture the bound material (bottom panels) was probed for
non-covalent interaction using anti-His (left panels) and anti-HSV (right panels) antibodies.
doi:10.1371/journal.ppat.1002023.g003
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adjacent to the start of the coiled-coil domain of LRIM1 and
APL1C in their ability to form homo- and heterodimers. To test
the flexibility of the location of the cysteine involved in LRIM
dimer formation, we expressed LRIM4C535S in Sf9 cells. When
CM was analyzed under reducing conditions, wild-type LRIM4
and LRIM4C535S both migrate at approximately 62 kDa,
consistent with the predicted size of a monomer (Figure 3C).
When analyzed under NR conditions, LRIM4C535S remains a
monomer whereas wild-type LRIM4 migrates at the predicted size
of a homodimer. These results indicate that LRIM4 C535 is
functionally equivalent to LRIM1 C352 and APL1C C562.
LRIM1C352S and APL1CC562S can form non-covalent
complexes
Even though LRIM1C352S and APL1CC562S do not form a
disulfide-linked complex, we wanted to determine whether these
proteins can interact non-covalently. We co-expressed His- and
HSV-tagged versions of LRIM1C352S and APL1CC562S in Sf9
cells. After confirming secretion of the proteins into the CM of the
transfected cells (Figure 3D), we performed His pull-down
experiments. Western analysis showed that the His-tagged
LRIM1C352S and APL1CC562S were efficiently captured from
the CM. Probing the captured material using an antibody against
the HSV tag revealed homo- and heteromeric interactions
between LRIM1C352S and APL1CC562S (Figure 3D). The relative
strength of the observed interactions directly parallels the abilities
of the wild-type proteins to homo- and heterodimerize (Figure 1);
LRIM1 and APL1C interact the strongest and APL1C dimerizes
more efficiently than LRIM1.
Analysis of the coiled-coil domain in LRIM1/APL1C
complex formation
To analyze how the coiled-coil domain of LRIM1 contributes to
secretion and complex formation, we transfected the set of coiled-
coil alleles into Sf9 cells. All of these produce proteins that are
secreted into the CM in similar abundance and migrate at their
expected relative sizes when analyzed under reducing conditions
(Figure 4A). NR western blot analysis of the CM revealed that
LRIM1DCCa, LRIM1DCCb and LRIM1DCC1 were present as both
monomers and homodimers (Figure 4B). In contrast, LRIM1DCC2,
missing C352, was exclusively monomeric. Next we co-expressed
the LRIM1 coiled-coil alleles with wild-type APL1C and analyzed
the CM under NR conditions. The LRIM1DCCa, LRIM1DCCb and
LRIM1DCC1 proteins were each present in an additional higher
molecular weight complex compared to when they were expressed
alone, indicating that these proteins can form heterodimers with
wild-type APL1C (Figure 4B). Again, the LRIM1DCC2 protein was
only present in the CM as a monomer, demonstrating that it is
unable to form complexes with itself or with APL1C. We
performed a similar series of experiments with His-tagged coiled-
coil alleles of APL1C and these behaved like their LRIM1
counterparts. All the APL1C coiled-coil alleles produced proteins
that were secreted into the CM and migrated at their expected
sizes when analyzed under reducing conditions (Figure 4C). When
analyzed under NR conditions we found that APL1CDCCa,
APL1CDCCb and APL1CDCC1 formed homodimers when ex-
pressed alone and heterodimers when co-expressed with wild-type
HSV-tagged LRIM1 (Figure 4D). The APL1CDCC2 protein,
missing C562, only produced a monomer both when expressed
alone or when co-expressed with wild-type LRIM1 (Figure 4D).
Despite lacking a coiled-coil domain, LRIM1DCC1 and
APL1CDCC1 can form homodimers when expressed alone and
heterodimers when co-expressed with a wild-type partner. This
suggests that the coiled-coil domain is not absolutely required for
complex formation. To test this using the natural protein pair, we
co-expressed His-tagged LRIM1DCC1 and HSV-tagged
APL1CDCC1 to determine if a heterodimer could form between
partners both lacking a coiled-coil domain. LRIM1DCC1 and
APL1CDCC1 were expressed alone or together and analyzed by
western blot for complex formation. As shown in Figure 4B and
4D, when expressed alone LRIM1DCC1 and APL1CDCC1 form
homodimers (Figure 4E). Co-expression of LRIM1DCC1 and
APL1CDCC1 produces a new complex containing both His and
HSV tags that is intermediate in size to the homodimers
(Figure 4E). Therefore, LRIM1DCC1 and APL1CDCC1 can form
homo- and heterodimers demonstrating that the coiled-coil
domain is largely dispensable for LRIM1/APL1C complex
formation.
The LRIM1/APL1C complex interacts with multiple TEP
family proteins
To identify novel proteins that may function with the LRIM1/
APL1C complex in parasite killing, we performed a large-scale
capture experiment from the mosquito hemocyte-like cell line that
was used previously to reveal an interaction between LRIM1/
APL1C and the mature form of TEP1 [6]. His-tagged LRIM1 and
APL1C were co-expressed and captured from the CM. Proteins
co-captured with the LRIM1/APL1C complex were separated on
a NR SDS-PAGE gel, visualized by staining with colloidal
Coomassie and identified by mass-spectrometry (MS) (Figure 5A).
The LRIM1 and APL1C homo- and heterodimers identified
migrate at a slightly greater molecular weight in this assay because
protein samples were separated on a fixed percentage gel (compare
Figure 5A to Figure 1). In addition to LRIM1 monomer and the
N- and C-terminal fragments of mature TEP1, we also identified
the N- and C-terminal fragments of TEP3, the C-terminal
fragment of TEP4 and the N-terminal fragment of TEP9
(Table 1). Therefore, the LRIM1/APL1C complex can interact
with the mature forms of 4 different TEP proteins in the CM of
mosquito cells. Band 4 at approximately 90 kDa was identified as
LRIM1. Since this is too small to be a homodimer, it is probably a
proteolytic fragment of a high molecular weight LRIM1 complex
(band 2 or 3). A positive MS identification could not be made for
band 5 that, based on molecular weight, is likely to be a monomer
of APL1C. Finally, band 8 was identified as an RNA poly-A
binding protein; however, given that this is an intracellular
protein, it is likely to be a contaminant.
TEP3 is an antagonist of P. berghei
Finding that the LRIM1/APL1C complex can interact with
more than one TEP family member suggests that these TEP
proteins may function in mosquito immune reactions against
Plasmodium parasites. Interestingly, two of the TEPs identified,
TEP3 and TEP4, were previously shown to play an important role
in bacterial defense [3,20]. We analyzed the role of TEP3 and
TEP4 on P. berghei infection intensity and melanization. After
TEP3 silencing, mosquitoes showed a highly significant increase in
developing oocysts 7 days post infection (Figure 5B). This increase
in oocysts was not as great as upon TEP1 silencing. In contrast,
silencing TEP4 had no effect on oocyst numbers, which is
consistent with a previous report [3]. Given the important role of
LRIM1, APL1C and TEP1 in parasite melanization, we next
assayed whether TEP3 or TEP4 also function in this process. To
test this, we silenced TEP3 and TEP4 together with CTL4, a
potent inhibitor of the melanization cascade [21]. Silencing CTL4
results in a striking increase in melanized ookinetes and a decrease
in live oocysts (Figure 5C). When TEP1 is silenced together with
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Figure 4. The coiled-coil domain of LRIM1 and APL1C is not required for heterodimer formation. Western blot analysis of Sf9 cell CM
samples following single transfection of indicated coiled-coil alleles (2) or co-transfection of coiled-coil alleles together with wild-type LRIM1 or APL1C
(+). Arrowheads: black, heterodimers; white, homodimers. (A) Reducing (R) analysis of LRIM1 coiled-coil alleles using an antibody against LRIM1. (B)
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CTL4, melanization is completely blocked and there is a dramatic
increase in live oocysts. Silencing of TEP3 and CTL4 together
results in an interesting intermediate phenotype whereby there is a
significant increase in oocysts but melanization is not significantly
reduced (Figure 5C). TEP4 silencing together with CTL4 has no
significant effect on oocysts numbers or parasite melanization.
Interaction between TEP1 or TEP3 with the LRIM1/APL1C
complex requires both TEP-N and TEP-C fragments
Given that the LRIM1/APL1C complex can interact with the
processed form of 4 different TEP proteins, we wanted to examine
if binding is mediated by the TEP-N or TEP-C fragments
independently or whether both are required. We generated HSV-
tagged expression constructs for full-length TEP1 and TEP3 and
their N- and C- terminal fragments. These TEPs were chosen
because both TEP1 and TEP3 are P. berghei antagonists. CM
containing HSV-tagged TEP protein fragments was mixed with
CM containing His-tagged LRIM1/APL1C. Following incuba-
tion, the LRIM1/APL1C complex was captured by the His tag
and samples were assayed for the presence of TEP fragments by
western blot using an antibody against HSV. For both TEP1 and
TEP3, we observed the strongest interaction between the LRIM1/
APL1C complex and CM containing both the TEP-N and TEP-C
fragments (Figure 6). Interactions between the individual frag-
ments and full-length TEP1 and TEP3 were considerably weaker
despite their similar abundance in the starting CM. These data
show that the LRIM1/APL1C complex interacts strongly with
TEPs only when they are processed and both N- and C- terminal
fragments are present.
TEP1 interacts with the coiled-coil domains of LRIM1 and
APL1C
To analyze the interaction of the LRIM1/APL1C complex with
TEP proteins, we performed binding assays between different
LRIM1 and APL1C alleles and TEP1-N and TEP1-C. These
assays aimed to reveal whether TEP1 can independently interact
with both LRIM1 and APL1C and whether interaction requires
disulfide-bonded complexes or an intact coiled-coil domain. We
chose the Sf9 binding assay described above because this system
lacks endogenous LRIMs and because in this system LRIM1 and
APL1C can interact non-covalently (see Figure 3D). Following
separate transfections, CM containing the LRIM1 and/or APL1C
variants was mixed with CM containing TEP1-N and TEP1-C.
Recombinant LRIM1 and APL1C proteins were captured using
their His tag and analyzed for TEP1 binding by western blot using
an HSV antibody. Strikingly, TEP1 is only captured by CM
containing the LRIM1/APL1C heterodimer (Figure 7A). It was
not present in samples containing only LRIM1 or APL1C
monomers and homodimers.
Next we tested the DCCa, DCCb and DCC1 coiled-coil alleles
of LRIM1 and APL1C expressed with a wild-type partner as well
as co-expressed DCC1 and DCC2 alleles. Finally, given that co-
expressed LRIM1C352S and APL1CC562S can interact non-
covalently we tested whether they can cooperate to bind TEP1.
We found that complexes between DCCa alleles with a wild-type
partner captured TEP1-N and TEP1-C, but all of the other
combinations of coiled-coil alleles lacked TEP1 binding despite a
similar amount of captured His-tagged proteins (Figure 7A). We
also observed strong binding between TEP1-N and TEP1-C when
we used CM containing both LRIM1C352S and APL1CC562S.
Taken together our results, summarized in Figure 7B, demonstrate
that TEP1 binds to the CCb region of the coiled-coil domain of
the LRIM1/APL1C heterodimer and that this binding requires
the presence of both LRIM1 and APL1C but not necessarily in a
covalent complex. The coiled-coil domains of LRIM1 and APL1C
are intertwined within the complex and adopt a helix-loop-helix
(HLH) fold [15], which would provide ample space for protein-
protein interaction. Our data reveal that the TEP1 binding site is
situated within this extensive coiled-coil region of the complex and
makes important contacts with the coiled-coil CCb domain.
To test the specificity of the LRIM1/APL1C interaction with
TEP1, we investigated whether the LRIM4 homodimer can also
interact with TEP1. We performed binding assays using the wild-
type LRIM4 construct expressed in a mosquito hemocyte-like cell
line described above. His-tagged LRIM4 was captured from the
CM and the samples were analyzed by western blot for TEP1. No
interaction was observed between LRIM4 and TEP1 (Figure S3A).
As controls we expressed both His-tagged LRIM1 and APL1C,
which can interact with their endogenous partner produced by
these cells and capture mature TEP1. This demonstrates that the
LRIM1/APL1C interaction with TEP1 is specific and not
common to other LRIM dimers. Furthermore, His-tagged LRIM4
did not interact with endogenous LRIM1 or APL1C produced by
these cells (data not shown). As LRIM4 does not interact with
TEP1, LRIM1 or APL1C, we hypothesized that LRIM4 is not
involved in P. berghei defense. Indeed, upon LRIM4 knockdown
there was no effect on P. berghei infection intensity or prevalence
(Figure S3B).
Discussion
The mosquito complement pathway plays a pivotal role in
infections with Plasmodium parasites. In this study we biochemically
dissect the structural features of the LRIM1/APL1C complex that
contribute to its formation and interaction with the complement
C3-like protein TEP1. LRIM1 and APL1C circulate in the adult
A. gambiae hemolymph exclusively as a heterodimer [6]. Similarly,
LRIM1 and APL1C primarily form a heterodimer when over-
expressed in Sf9 or cultured mosquito cell lines. However, they can
also form monomers and homodimers suggesting that these
alternative forms are either highly unstable in the hemolymph or
retained intracellularly due to stricter quality control mechanisms.
Numerous disulfide-bonded heterocomplexes, similar to
LRIM1/APL1C, have been discovered with key roles in
immunity, hemostasis and complement activation. Notable
examples include the IgG heavy and light chain peptides, platelet
glycoproteins Iba and Ibb [22] and importantly, the extensive
repertoires of secreted variable lymphocyte receptor (VLR)
antibodies in jawless vertebrates [23,24]. Our study reveals that
C352 of LRIM1 and the homologous residue, C562, of APL1C
play a crucial role in covalently linking these proteins through a
disulfide bond, which is consistent with direct apposition of these
residues in the LRIM1/APL1C crystal structure [15]. Important-
ly, we show that this disulfide linkage is not necessary for the
interaction between LRIM1 and APL1C or between the complex
NR analysis of LRIM1 coiled-coil alleles transfected alone and together with wild-type APL1C. Note, there are homomeric complex bands present in
the co-transfection of wild-type APL1C for both LRIM1DCCb and LRIM1DCC1. (C) Reducing analysis of APL1C coiled-coil alleles using an antibody against
their C-terminal His-tag. (D) NR analysis of APL1C coiled-coil alleles transfected alone and together with wild-type LRIM1. Note, there are homomeric
complex bands present in the co-transfection of wild-type LRIM1 for both APL1CDCCb and APL1CDCC1. (E) NR western analysis of LRIM1 and APL1C
single and co-transfection using anti-LRIM1 (left) and anti-HSV antibodies (right) to distinguish LRIM1 and APL1C containing complexes, respectively.
doi:10.1371/journal.ppat.1002023.g004
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Figure 5. Multiple TEP family members interact with LRIM1 and APL1C. (A) Coomassie stained NR SDS-PAGE gel of proteins captured from
CM of Sua4.0 cells transfected with His-tagged LRIM1 and APL1C. Arrows indicate protein bands analyzed by MS (also see Table 1). Note, the
difference in mobility of high-molecular weight LRIM1 and APL1C complexes compared to Figure 1 is due to protein separation on 8% non-gradient
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and the processed form of TEP1. This observation raises an
important question about the role of the disulfide bond in the
function of the LRIM1/APL1C complex. It is possible that the
disulfide bond is necessary for the release of TEP1 from the
complex during an immune response. For example, it might act as
a molecular hinge and allow for a productive conformational
change required for TEP1 release. Alternatively, it may increase
the stability of the complex in the mosquito hemolymph and/or
prevent the two proteins from acting independently, e.g. as
homodimers.
The dispensability of the disulfide bridge in the formation of the
LRIM1/APL1C complex also suggests that LRIM family
members lacking a free cysteine residue in their C-terminal region
may still be capable of forming homodimers or heterodimers. In
addition, by including LRIM4 in our analysis, we demonstrate
that the location of the bridging cysteine residue is flexible: despite
its position on the opposite side of the coiled-coil domain, C535 of
LRIM4 appears capable of forming an intermolecular disulfide
bond. It remains to be seen whether the LRIM4 homodimer
adopts a similar or different structure to the LRIM1/APL1C
heterodimer [15]. Although LRIM4 (also referred to as LRRD5) is
highly upregulated in the A. gambiae midgut after P. falciparum
infection [3], little is known about its functional role in the innate
immune response. We demonstrate here that silencing LRIM4 has
no effect on P. berghei infection and that the protein does not
interact with TEP1, LRIM1 or APL1C.
We show that mutations in LRIM1 of each of the remaining
cysteine residues located in the region between the LRR and the
coiled-coil domains (C273, C305, C317 and C318) yield proteins
that are trapped within the cell and unable to be secreted into the
CM even when expressed with a wild-type APL1C. Thus mutation
of these cysteines is likely to grossly affect protein folding. These
cysteines form two intramolecular disulfide bonds [15] and their
location in all members of the LRIM protein family is at the end of
the LRR domain [12]. Intramolecular disulfide bonds between
adjacent cysteines in this region may generate a family-specific C-
terminal cap similar to those identified in other LRR proteins [25].
Given the importance of these cysteines to the correct folding of
LRIM1, it is interesting to note that the double cysteine motif in
Transmembrane (TM) LRIMs is replaced by a tyrosine-cysteine
pair [12]. Members of this LRIM subfamily are predicted to only
form a single intramolecular bond and leaving a cysteine free to
potentially form an intermolecular bridge.
Expression of various mutant or deletion LRIM1 or APL1C
alleles together with their wild-type partners, respectively,
implicate the cysteine-rich region as the key determinant in
LRIM1/APL1C complex formation and reveal that the coiled-coil
domain of these proteins is largely dispensable for heterodimer
complex formation. However, we show that the most carboxy-
terminal coiled-coil region (CCb) may play a role in the specificity
of LRIM1 and APL1C interaction. When co-expressed with their
wild-type partner, proteins lacking CCb form homo- and
heterodimers with equal efficiency whereas those possessing CCb
favor heterodimer formation. Importantly, the CCb region of both
LRIM1 and APL1C is critical for binding to mature (processed)
TEP1 altogether raising the intriguing possibility that TEPs may
be involved in the specificity of complex formation.
We have revealed that the combined coiled-coil domain of the
LRIM1/APL1C heterodimer is the binding site of mature TEP1
and that homodimers of LRIM1 and APL1C do not bind TEP1.
In addition to revealing an interaction with mature TEP1, which
was previously shown [5,6], our MS analysis of proteins
interacting with the LRIM1/APL1C complex revealed mature
forms of 3 other TEP family members. It is not known whether
LRIM1/APL1C interacts with each TEP individually and
competitively under different circumstances. However, the report-
ed 1:1 stoichiometry of TEP1 to LRIM1/APL1C heterodimer
[15], makes it likely that different TEPs form independent
complexes with LRIM1/APL1C.
We demonstrate that one of the TEPs we found to interact with
the LRIM1/APL1C complex, TEP3, is also an antagonist of P.
berghei infections. As the increase in oocysts upon TEP3 silencing is
not as dramatic as with LRIM1, APL1C and TEP1, we speculate
that TEP3 is either redundant or has a more indirect role in P.
berghei killing. Another possible explanation is that TEP3
participates in a Plasmodium defense pathway that is distinct from
or complementary to that of TEP1. This is consistent with the
requirement of both TEP3 and LRIM1 for phagocytosis of gram-
negative but not gram-positive bacteria whereas TEP1 is
important for both [20]. Importantly, unlike TEP1, TEP3 has
an inactive thioester motif [26], and although TEPs lacking an
active thioester are reported to play a role in immune reactions
such as phagocytosis [27] their function may be regulatory rather
than structural. It remains to be determined whether TEP3
functions against the human malaria parasite, P. falciparum.
The LRIM1/APL1C complex also interacts with the mature
form of TEP4 that plays an important role in bacterial defense and
phagocytosis [3,4,20]. TEP4 has been previously shown to be
upregulated by P. berghei infections [28], but we show here that it
has no effect against P. berghei. Therefore, we hypothesize that
gel. (B) Midgut oocyst numbers from mosquitoes treated with double-stranded (ds)GFP, dsTEP1, dsTEP3 and dsTEP4 RNA dissected 7 days after
infection with GFP-expressing P. berghei. (C) Midgut oocyst and melanized ookinete numbers from mosquitoes treated with dsCTL4 RNA alone or in
combination with dsTEP1, dsTEP3 and dsTEP4 RNA. dsTEP1, dsTEP3 and dsTEP4 treated mosquitoes are compared to live oocyst and melanized
ookinete numbers in the dsCTL4 group. Mosquitoes treated with dsCTL4 RNA alone have significantly fewer live oocysts and greater melanized
ookinetes than dsGFP treated controls (P,0.0001, not indicated). Median parasite number indicated by a horizontal line and samples with significant
Mann-Whitney P-values ,0.0001 and ,0.05 labeled with an asterisk in panels B and C, respectively.
doi:10.1371/journal.ppat.1002023.g005
Table 1. Mass-spectrometry identification of proteins
interacting with the LRIM1/APL1C complex.
Band MS identification (id) Hits
1 APL1C (AGAP007033) 4
2 LRIM1 (AGAP006438), APL1C 7, 14
3 LRIM1 3
4 LRIM1 2
5 ND
6 TEP1-C (AGAP010815) 13
7 TEP1-C, TEP3-C (AGAP010816), TEP4-C (AGAP010812) 4, 8, 2
8 TEP1-N, TEP3-N, TEP9-N (AGAP010830), polyA binding
protein (AGAP011092)
5, 3, 4, 3
9 LRIM1 4
Proteins bands (Figure 5A) and their gene identifier are listed together with the
number of peptide hits positively identified by Mascot analysis, except for band
5, which was not determined (ND).
doi:10.1371/journal.ppat.1002023.t001
Structure-Function of the LRIM1/APL1C/TEP1 Complex
PLoS Pathogens | www.plospathogens.org 10 April 2011 | Volume 7 | Issue 4 | e1002023
Figure 6. Both N- and C-terminal fragments are required for TEP1 and TEP3 interactions with the LRIM1/APL1C complex. Input CM
(top panel) from Sf9 cells transfected with secreted GFP (sGFP), full-length (FL) TEP1 and TEP3 or their N- and C-terminal fragments individually (N and
C) or together (N+C) was analyzed by western blot using an anti-HSV antibody. Input CM was mixed with His-tagged LRIM1/APL1C. His-bound
material was probed with anti-HSV antibody (middle panel) and His-probe (lower panel).
doi:10.1371/journal.ppat.1002023.g006
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LRIM1/APL1C and TEP4 cooperate in a defense mechanism
against bacteria and that the TEP4 upregulation is due to
opportunistic infections with gut bacteria that occur during
Plasmodium traversal of the mosquito midgut epithelium. Both
TEP3 and TEP4 are strongly upregulated by bacteria [29].
Our finding that the LRIM1/APL1C complex can interact with
multiple members of the TEP protein family opens new avenues
for investigating how mosquitoes may generate pathogen-specific
immune responses. For example, LRIM1, APL1C and TEP1 have
a prominent role in mosquito defense against P. berghei, but of these
proteins only TEP1 has been shown to play a role in controlling
infections with human malaria parasites, P. falciparum [3,30,31].
Just as the LRIM1/APL1C complex can interact with multiple
TEP proteins, it is possible that TEP1 may also interact with
multiple LRIM family members. APL1A and LRIM17 are
attractive candidates given that they have been shown to be
antagonists of P. falciparum [3,31]. APL1A is a particularly
intriguing candidate since it is 61% identical to APL1C in the
coiled-coil region that contributes to the TEP1 binding site. The
same region of APL1B is 78% identical to APL1C, and although
APL1B has been shown to be dispensable for defense against P.
berghei and P. falciparum [31], it may interact with TEP1 in a
pathogen-specific manner. Future research is important to
determine whether TEP1 exists in different complexes in the
mosquito hemolymph and if such complexes contribute to
pathogen-specific responses.
In this paper we provide the biochemical framework for
understanding the role of the LRIM1/APL1C complex in
regulating mosquito immunity to Plasmodium. Taken together,
our data reveal that the LRIM1/APL1C complex is organized
into three distinct modules as summarized in Figure S4. The
central region containing a pattern of conserved cysteine residues
is largely responsible for LRIM1/APL1C complex formation,
while the coiled-coil may also contribute to the specificity of the
interaction. The combined C-terminal coiled-coil region functions
to carry different TEP cargoes. We show that at least four different
TEP family members with distinct and overlapping roles in
mosquito innate defense bind to the LRIM1/APL1C complex.
Finally, we hypothesize that the LRR domains of LRIM1 and
APL1C function in activation of the complex, possibly through
recognition of pathogen surfaces directly or via an interaction with
other immune receptors. What triggers the release of mature
TEP1 from the LRIM1/APL1C complex is important to
understanding how the mosquito complement pathway targets
and eliminates malaria parasites.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986. The protocols
for maintenance of mosquitoes by blood feeding and for infection
of mosquitoes with P. berghei by blood feeding on parasite-infected
mice were approved and carried out under the UK Home Office
License PLL70/6347 awarded in January 2008. The procedures
are of mild to moderate severity and the numbers of animals used
are minimized by incorporation of the most economical protocols.
Opportunities for reduction, refinement and replacement of
animal experiments are constantly monitored and new protocols
are implemented following approval by the Imperial College
Ethical Review Committee.
Generation of LRIM1, APL1C and LRIM4 alleles
Alleles of LRIM1, APL1C and LRIM4 were generated by PCR
using pIEx10 clones as templates and primers listed in the Table
S1. Products were LIC cloned (Merck Chemicals) into a dual
Strep- and His-tag vector (pIEx10) or InFusion cloned (Clontech)
into an HSV-tag (pIEx1SPmyc) vector. The pIEx1SPmyc vector is a
variant of the pIEx1 (Merck Chemicals) that retains its C-terminal
HSV tag but was modified to contain an N-terminal IgM signal
peptide and Myc epitope tag. Cysteine and DCCa alleles of
LRIM1 and APL1C were generated by splice-overlap extension
(SOE) PCR [32] using outer ‘‘His’’ and inner allele-specific
primers. The LRIM4C535S missense mutation was created using the
QuikChange II Site-Directed Mutagenesis protocol (Stratagene).
All constructs were verified by DNA sequencing.
Western blot conditions
Protein samples were separated on 8% or 4-15% Criterion
SDS-PAGE gels (Bio-Rad). NR samples were prepared in Lane
Marker sample buffer (Pierce). Reduced samples were made by
supplementing NR samples with a tris(2-carboxyethyl)phosphine
(TCEP) solution (Pierce) to a final concentration of 25 mM and
heating at 95uC for 5 min. Transfer to PVDF and western
conditions were previously described [6] except for rabbit a-GFP
(1:1000 diluted in PBS + 0.05% Tween 20 and 3% milk), mouse a-
Strep-tag (1:200) and goat a-HSV-tag (1:1000) diluted in PBS +
0.05% Tween 20 and 3% BSA.
Protein expression, purification and mass spectrometry
Analysis of LRIM1, APL1C and LRIM4 alleles was performed
using the CM of transfected Sf9 cells adapted to growth in serum-
free (SFM) culture medium (Sf-900 II, Invitrogen). Cells were
transfected using Escort IV reagent (Sigma) and CM was collected
3-4 days post transfection, cleared of debris by centrifugation or by
passage through a 0.45 mm filter and supplemented with NR
sample buffer. Unless noted, a 2:1 mg ratio of APL1C to LRIM1
was used in all co-transfection experiments to achieve comparable
expression levels. Hemolymph was collected as described previ-
ously [6]. For MS analysis, mosquito Sua4.0 cells were transfected
using Effectene (Qiagen) at 80–90% confluence in non-vented
175 mm2 culture flasks. DNA complexes were made by diluting
7.5 mg of pIEx10-LRIM1 and 17.6 mg pIEx10-APL1C with 1.3 mL
EC buffer and then adding 40 mL of enhancer followed by 125 mL
of Effectene reagent. Complexes were added to cells dropwise and
incubated for 12 h in Schneider’s Drosophila (S2) medium
containing 10% heat-inactivated FCS. Cells were washed with
and then placed in 30 mL of serum-free S2 medium for
conditioning. CM was collected after 5 days, passed through a
0.45 mm syringe filter into a conical tube and supplemented with
0.05% triton X-100. A slurry of 650 mL (packed volume) of Ni-
NTA agarose (Qiagen) in PBS was added to the CM and mixed
for 2 h at room temperature. Beads were washed once in the tube
Figure 7. The coiled-coil CCb domain of LRIM1 and APL1C is required for TEP1 interaction. (A) CM containing LRIM1 and APL1C alleles
indicated and the control (sGFP) were captured after mixing with input CM containing TEP1-N and TEP1-C. Capture of the LRIM1 and APL1C proteins
was confirmed by western analysis of the His tag (top panel) or for TEP1-N and TEP1-C fragments using their HSV tag (bottom panel) on an 8% SDS-
PAGE gel. (B) Summary of binding strength between LRIM1/APL1C coiled-coil complexes and TEP1-N and TEP1-C fragments. Features indicated:
binding (+); no binding (-); red dashed line, disulfide bond; yellow star, cysteine to serine missense mutation; dashed line, in-frame deletion. Colored
boxes denote coiled-coil DCCa and DCCb domains: green, LRIM1; blue, APL1C.
doi:10.1371/journal.ppat.1002023.g007
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with buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM
imidazole pH 8.0) and then transferred to a 10 mL disposable
column for further washes. Bound proteins were eluted in 10 mL
of wash buffer containing 250 mM imidazole and then concen-
trated to approximately 100 mL using a 10 kDa cutoff Amicon
Ultra filter (Millipore). Samples were made by the addition of NR
buffer, separated on an 8% SDS-PAGE gel, stained with Imperial
stain (Pierce) and imaged before MS identification of individual
bands (performed at EMBL).
Binding assays
TEP1 binding assays of LRIM1 and APL1C alleles were
performed using the CM of transfected Sf9 cells. Cells were
transfected independently with pIEx1SPmyc-TEP and pIEx10-
APL1C/pIEx10-LRIM1 vectors. 200 mL of each CM was mixed
and supplemented with 0.1% triton X-100 and 5 mL of a 1:1 slurry
of Talon resin (Stratagene) in PBS. After a 3 h incubation at room
temperature the beads were washed in PBS containing 0.1% triton
X-100 and extracted with 35 mL of 2x NR loading buffer. Binding
between LRIM1C352S and APL1CC562S was determined by
performing His pull-down assays using CM from Sf9 cells co-
transfected with pIEx10-LRIM1C352S and pIEx1SPmyc-APL1CC562S
plasmids, respectively. TEP1 binding assays for wild-type LRIM4
were performed using the CM of transfected mosquito Sua4.0 cells
as described previously [6].
Mosquito maintenance, gene silencing and infection
The N’gousso strain of A. gambiae was maintained as described
previously [33,34]. Mosquitoes were cultured and infected with P.
berghei CONGFP strain [35] as described previously [11]. Single
and double knockdown experiments and parasite counts in
dissected midguts were performed as described previously [6].
Primers used for synthesis of double stranded RNA are listed in
Table S1.
VectorBase gene identifiers
LRIM1, AGAP006348; APL1C, AGAP007033; LRIM4, AGA
P007039; TEP1, AGAP010815; TEP3, AGAP010816; TEP4,
AGAP010812; TEP9, AGAP010830; polyA-binding protein,
AGAP011092; S7, AGAP010592; CTL4, AGAP005335.
Supporting Information
Figure S1 Probability of coiled-coil and coiled-coil
multimer formation in LRIM1 and APL1C. (A) Potential
for coiled-coil formation as a function of amino acid position [19].
Red double arrow indicates the region between the coiled-coil
CCa and CCb domains (black double arrow) with very low
probability of coiled-coil formation. (B) Potential for coiled-coil
multimers [36]. Lines indicated: green, dimer probability; blue,
trimer probability; gray with shaded area underneath, total
multimer probability (dimers and trimers); Dashed line indicates
the 80% threshold.
(TIF)
Figure S2 LRIM1 cysteine allele protein expression in
transfected Sf9 cells. One day after transfection with indicated
LRIM1 cysteine alleles, cells were fixed, permeabilized and labeled
with GFP or LRIM1 (red, middle panels) or Strep-tag (green, top
panels) antibodies. DIC images (bottom panels) show an
approximately equal number of cells were analyzed for each
allele. The scale for all pictures is identical. Scale bar in the top left
panel is 20mm.
(TIF)
Figure S3 LRIM4 does not interact with TEP1 and does
not affect P. berghei development. (A) CM input (left panels)
and His-captured samples (right panels) from Sua4.0 cells
transfected with sGFP, LRIM4, APL1C and LRIM1 analyzed
by NR western blot using the His-tag (top panels) or an antibody
against TEP1 (bottom panels). (B) Midgut oocyst numbers from
mosquitoes treated with dsGFP, dsLRIM4 and dsLRIM1 RNA
dissected 7 days after infection with GFP-expressing P. berghei.
Prevalence of infection was 91%, 96% and 100% for dsGFP,
dsLRIM4 and dsLRIM1, respectively. Median parasite number
indicated by a horizontal line and samples with significant Mann-
Whitney P-values (,0.0001) labeled with an asterisk.
(TIF)
Figure S4 The modular organization of the LRIM1/
APL1C heterodimer. Schematic representation of the LRIM1/
APL1C complex with its 3 modules highlighted.
(TIF)
Table S1 Primer sequences. Primers used for generation of
dsRNA, qRT-PCR and protein expression constructs. For LIC
cloning into pIEx10 His F primers have GACGACGACAAGATG
and His R primers have GAGGAGAAGCCCGGTTT at their 59
end indicated by a * symbol. For InFusion cloning into pIEx1SPmyc
HSV F primers have TACCGGTTCGAAGCTT and HSV R
primers have GTGCGGCCGCAAGCTT at their 59 end
indicated by a # symbol. SOE PCR fragments generated by
primer pairs His F/f1 R and f2 F/His R were mixed and used as a
template in a reaction with His F/His R to generate full-length
products.
(DOC)
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